Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Oxidation phenotype--a major determinant of metoprolol metabolism and response.

× No keyword cloud information.

84 in total

Review 1. Use of gene markers to guide antihypertensive therapy.

Authors: S T Turner; G L Schwartz; A B Chapman; E Boerwinkle
Journal: Curr Hypertens Rep Date: 2001-10 Impact factor: 5.369

2. Influence of debrisoquine oxidation phenotype on exercise tolerance and subjective fatigue after metoprolol and atenolol in healthy subjects.

Authors: R V Lewis; L E Ramsay; P R Jackson; W W Yeo; M S Lennard; G T Tucker
Journal: Br J Clin Pharmacol Date: 1991-04 Impact factor: 4.335

3. Lack of effect of omeprazole treatment on steady-state plasma levels of metoprolol.

Authors: T Andersson; P Lundborg; C G Regårdh
Journal: Eur J Clin Pharmacol Date: 1991 Impact factor: 2.953

4. Inhibition of CYP2D6 by quinidine and its effects on the metabolism of cilostazol.

Authors: S L Bramer; A Suri
Journal: Clin Pharmacokinet Date: 1999 Impact factor: 6.447

5. Polymorphic metabolism of metoprolol: clinical studies.

Authors: J H Silas; J C McGourty; M S Lennard; G T Tucker; H F Woods
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

6. Effect of oxidative polymorphism (debrisoquine/sparteine type) on hepatic first-pass metabolism of bufuralol.

Authors: P Dayer; L Balant; A Kupfer; R Striberni; T Leemann
Journal: Eur J Clin Pharmacol Date: 1985 Impact factor: 2.953

7. Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies.

Authors: J C McGourty; J H Silas; M S Lennard; G T Tucker; H F Woods
Journal: Br J Clin Pharmacol Date: 1985-12 Impact factor: 4.335

Review 8. CYP2D6 polymorphism and its impact on the clinical response to metoprolol: A systematic review and meta-analysis.

Authors: Maxime Meloche; Michael Khazaka; Imad Kassem; Amina Barhdadi; Marie-Pierre Dubé; Simon de Denus
Journal: Br J Clin Pharmacol Date: 2020-04-05 Impact factor: 4.335

9. A convenient five-drug cocktail for the assessment of major drug metabolizing enzymes: a pilot study.

Authors: Ashish Sharma; Sylvie Pilote; Pierre M Bélanger; Marie Arsenault; Bettina A Hamelin
Journal: Br J Clin Pharmacol Date: 2004-09 Impact factor: 4.335

10. Pharmacokinetic and pharmacodynamic comparison of a new controlled-release formulation of metoprolol with a traditional slow-release formulation.

Authors: B Oosterhuis; J H Jonkman; F A Kerkhof
Journal: Eur J Clin Pharmacol Date: 1988 Impact factor: 2.953